Bioelectronic Medicine

Cala Health Receives FDA Breakthrough Device Designation for Cala Trio™ Therapy to Treat Action Tremors in Parkinson’s Disease | Business Wire | 10/22/2020

BURLINGAME, Calif.–(BUSINESS WIRE)–Oct 22, 2020– Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Cala Trio™ for the treatment of action tremors in the hands of adults with Parkinson’s disease. Cala Trio is currently FDA-cleared to relieve hand tremors from essential tremor (ET). The Company expects to initiate …

electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business Unit | Globe Newswire | 10/21/2020

Newly created position to focus on driving growth within the Veterans Administration, Department of Defense and other government channels October 21, 2020 08:00 ET Source: electroCore BASKING RIDGE, N.J., Oct. 21, electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the appointment of Sylvester “Sly” Steele to the newly created position of Vice President and General Manager of the Government Channels Business Unit. Mr. Steele brings to …

Follow Bioelectronic Medicine:    

Spinal Cord Stimulation Alleviates Motor Symptoms in Parkinson’s Disease Patients | 9/29/2020

… singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies are found ineffective, according to a team of researchers in the United States and Japan. The study findings were published in Bioelectronic Medicine . Krishnan Chakravarthy, MD, PhD, assistant professor of anesthesiology at University of California San Diego School of Medicine, and colleagues recruited 15 patients with Parkinson’s disease. ‘Spinal cord stimulation may be therapeutically beneficial for patients …

Spinal cord stimulation reduces pain and motor symptoms in Parkinson’s disease patients | 9/28/2020

… and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective. advertisement Writing in the September 28, 2020 issue of Bioelectronic Medicine , first author Krishnan Chakravarthy, MD, PhD, assistant professor of anesthesiology at University of California San Diego School of Medicine, and colleagues recruited 15 patients with Parkinson’s disease, a neurodegenerative disorder that is commonly characterized …

** | 9/28/2020**

Some of the most influential international experts, researchers, and scientific minds participated in the Fourth Bioelectronic Medicine Summit: Technology Targeting Molecular Mechanisms, hosted by The Feinstein Institutes for Medical Research – the global scientific home of bioelectronic medicine – on September 23 and 24. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200928005523/en/ Drs. Kevin Tracey, Valentin Pavlov, Sangeeta Chavan welcome participants to the 2020 …

Fourth Bioelectronic Medicine Summit Showcases Broad Innovation | Business Wire | 9/28/2020

MANHASSET, N.Y.- Some of the most influential international experts, researchers, and scientific minds participated in the Fourth Bioelectronic Medicine Summit: Technology Targeting Molecular Mechanisms, hosted by The Feinstein Institutes for Medical Research – the global scientific home of bioelectronic medicine – on September 23 and 24. Bioelectronic medicine combines molecular medicine, neuroscience, and biomedical engineering to develop innovative therapies to treat a variety of diseases and conditions through targeted stimulation of nerves …

Fourth Bioelectronic Medicine Summit Showcases Broad Innovation | 9/28/2020

Fourth Bioelectronic Medicine Summit Showcases Broad Innovation [September 28, 2020] Fourth Bioelectronic Medicine Summit Showcases Broad Innovation Some of the most influential international experts, researchers, and scientific minds participated in the Fourth Bioelectronic Medicine Summit: Technology Targeting Molecular Mechanisms, hosted by The Feinstein Institutes for Medical Research - the global scientific home of bioelectronic medicine - on September 23 and 24. This press release features multimedia. View the full release here: https …

First Real-World Evidence Demonstrates Cala Trio’s Effectiveness in Essential Tremor with Individually Calibrated, Non-Invasive Stimulation | BioSpace | 9/14/2020

First Real-World Evidence Demonstrates Cala Trio’s Effectiveness in Essential Tremor with Individually Calibrated, Non-Invasive Stimulation Published: Sep 14, 2020 BURLINGAME, Calif.–( BUSINESS WIRE )– Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today presented data demonstrating that Cala Trio™ therapy is safe and effective in improving tremors in patients with essential tremor (ET) when used at home, unsupervised, and under real-world conditions. These …

electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Investment Conference | Globe Newswire | 9/11/2020

BASKING RIDGE, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) – electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to present at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held from September 14-16, 2020. Presentation details: Date: Wednesday, September 16, 2020Time: 1:30-1:50pm EDT A live webcast of the presentation will be available on the Investors section of the company’s website …

Oregon scientists use 3D printed nerve tingling device to better understand birdsong | 9/11/2020

… a number of zebra finch test subjects, evoking distinct predetermined vocalizations. In the future, the technology behind the tiny device could be deployed within keyhole surgical applications, or even in the creation of new bioelectronic medicine s for diseases such as diabetes or arthritis. “Imagine you had to manipulate a small nerve and wrangle a device onto it using forceps to both open a cuff electrode and position it on the …

electroCore to Present at the HC Wainwright Virtual 22nd Annual Global Investment Conference | BioSpace | 9/11/2020

BASKING RIDGE, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) – electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to present at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held from September 14-16, 2020. Presentation details: Date: Wednesday, September 16, 2020 Time: 1:30-1:50pm EDT A live webcast of the presentation will be available on the Investors section of the company’s …

ReShape Lifesciences™ Announces Positive Preclinical Results for Its Investigational Diabetes Bloc-Stim Neuromodulation Device | BioSpace | 9/10/2020

ReShape Lifesciences™ Announces Positive Preclinical Results for Its Investigational Diabetes Bloc-Stim Neuromodulation Device Published: Sep 10, 2020 SAN CLEMENTE, Calif. , Sept. 10, 2020 /PRNewswire/ – ReShape Lifesciences (Formally known as EnteroMedics) Inc., (OTCQB: RSLS) a global weight-loss solutions leader, today announced preclinical research demonstrating the Company’s investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™) proprietary device for the treatment of type 2 diabetes mellitus (T2DM) was well-tolerated and met the …

ReShape Lifesciences™ Announces Positive Preclinical Results for Its Investigational Diabetes Bloc-Stim Neuromodulation Device - GuruFocus.com | 9/10/2020

Study funded by National Institutes of Health Small Business Innovation Research Phase I grant PR Newswire SAN CLEMENTE, Calif., Sept. 10, 2020 SAN CLEMENTE, Calif. ReShape Lifesciences Inc., (OTCQB: RSLS) a global weight-loss solutions leader, today announced preclinical research demonstrating the Company’s investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™) proprietary device for the treatment of type 2 diabetes mellitus (T2DM) was well-tolerated and met the study endpoints. The study …

Stocks for the Bioelectronic Medicine Revolution (NVCR, EMED, ECOR) | 9/9/2020

… medical establishment with evidence of its efficacy, especially as an alternative to potentially dangerous drugs, including opioid-based painkillers responsible for the current epidemic of addiction and death by overdose. The basic premise behind Bioelectronic medicine is to solve health issues by tapping into the body’s natural electrochemical operating system. On a very fundamental level, the body works by electricity – in every cell, throughout the nervous system, even at the …

Feinstein Institutes Receives $1.7M Grant to Study Behavior Change Science, Promote Exercise in Older Adults | Business Wire | 9/9/2020

… in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine , cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that …

Feinstein Institutes Receives $1.7M NIH Grant to Study Origins of Hereditary Blood Disorder | Business Wire | 9/8/2020

… in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine , cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that …

Personalised Bioelectrical Treatment Using DNA Sequencing | 9/4/2020

… and illness. Muhdo’s DNA and epigenetic analysis allows for a personal understanding of a user’s own recovery and inflammation and NuroKor’s devices help the user to take control of it. Using scientifically-proven, personalised bioelectronic medicine , NuroKor can support pain management and injury rehabilitation, as well as improving recovery from exercise and training. For further information see the IDTechEx repoerton Bioelectronic Medicine 2019-2029 . As healthcare moves towards individualised treatments, so …

COVID-19, Pancreatitis Link Identified by Feinstein Institutes Researchers | Business Wire | 9/4/2020

… in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine , cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that …

electroCore Inc. (NASDAQ: ECOR) Featured in Virtual Coverage of The LD 500 | Wordpress.com | 9/2/2020

electroCore Inc. (NASDAQ: ECOR) is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation (nVNS) therapy, which is initially focused on the treatment of multiple conditions in neurology. The company’s current indications are for the preventative treatment of cluster headache and acute treatment of migraine and episodic cluster headache. electroCore has secured an extensive intellectual property portfolio, with more than …

ELCQ Sets Up as Pure-Play on Bioelectronic Medicine Revolution | 8/31/2020

One stock that promises some interesting action ahead is Electromedical Technologies Inc (OTCMKTS:ELCQ). The company is a first-mover leading-edge pure play in the emerging field of Bioelectronic medicine, which has rapidly growing roots in the medical establishment after years of skepticism overwhelmed by legit peer-reviewed research that shows it works. The basic premise behind Bioelectronic medicine is to solve health issues by tapping into the body’s …

Bioelectronic medicine advances with 3D printed nanoclip nerve stimulator | 8/31/2020

About the diameter of a human hair, the device could lead to the development of bioelectronic therapies that target chronic problems such as asthma or hypertension. The nanoclip decodes and modulates electrical signals traveling in the peripheral nervous system, which Rendering of a thin-film-integrated nanoclip nerve interface showing key components. Source: Timothy M. Otchy et al. contains nerves and neuronal cells outside the brain and spinal cord that …

Scientist unveils a 3-D printed device to excite nerves | 8/28/2020

A tiny, thin-film electrode with a 3-D-printed housing has been implanted in the peripheral nervous system of songbirds, where it successfully recorded electrical impulses that drive vocalizations. The research is seen as an advance in the emerging field of bioelectronic medicine and eventually could lead to a new treatment for diseases such as inflammatory bowel syndrome, rheumatoid arthritis and diabetes, said Tim Gardner, a neuroscientist at the …

Electromedical Technologies Issues Letter to Shareholders Outlining the Opportunity Ahead | Globe Newswire | 8/27/2020

SCOTTSDALE, Electromedical Technologies, Inc. (OTC: ELCQ) (“Electromedical Technologies” or the “Company”), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro®, designed to relieve chronic, intractable and acute pain by using frequencies and electro-modulation, issues the following Letter to Shareholders on behalf of the CEO: Dear Valued Shareholder, With a number of significant research, partnership, and product catalysts dead ahead, we believe we are …

Electromedical Technologies Issues Letter to Shareholders Outlining the Opportunity Ahead | BioSpace | 8/27/2020

Electromedical Technologies Issues Letter to Shareholders Outlining the Opportunity Ahead Published: Aug 27, 2020 SCOTTSDALE, Ariz., Aug. 27, 2020 (GLOBE NEWSWIRE) – Electromedical Technologies, Inc. (OTC: ELCQ) (“Electromedical Technologies” or the “Company”), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro®, designed to relieve chronic, intractable and acute pain by using frequencies and electro-modulation, issues the following Letter to Shareholders on behalf of the …

electroCore Announces Publication in Brain Stimulation Highlighting Non-Invasive Vagal Nerve Stimulation’s (nVNS) Potential Role in Treatment of Post-Traumatic Stress Disorder (PTSD) | Globe Newswire | 8/27/2020

BASKING RIDGE, N.J., Aug. 27, 2020 (GLOBE NEWSWIRE) – electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a paper, entitled, “Non-invasive vagal nerve stimulation decreases brain activity during trauma scripts 1 ,” by Wittbrodt, Bremner et. al. in the journal Brain Stimulation. The paper reports on a double-blind sham-controlled study of nineteen participants who had experienced trauma but did not have the …